28 results on '"Legg, J."'
Search Results
2. P158 Elexacaftor, tezacaftor, ivacaftor (ETI) improves lung function but not rate of decline in a two year observational study of adolescents
3. P120 Adherence to elexacaftor/texacaftor/ivacaftor during the first 2 years of treatment in an adolescent population
4. P118 Real-world impact of elexacaftor/tezacaftor/ivacaftor on quality of life of children with cystic fibrosis aged 6–11 years and primary caregivers in the UK: MAGNIFY, a prospective, observational, non-interventional study
5. EPS5.08 Elexacaftor/tezacaftor/ ivacaftor reduces need for pancreatic enzymes, enteral feeding and omeprazole use without causing excessive weight gain: a 2-year observational study
6. WS03.05 Percentage days covered: what does it tell us about adherence to Kaftrio and Kalydeco®?
7. P460 Assessing the exercise capacity of adolescents with cystic fibrosis in the post elexacaftor/tezacaftor/ivacaftor era, via cardiopulmonary exercise test.
8. P361 A qualitative assessment of the relative benefits of Insight on-line and I-adhere software in assessing nebuliser usage
9. ePS4.06 Vitamin E in paediatric patients with cystic fibrosis - is supplementation routinely required?
10. 254 Feasibility of implementing cardiopulmonary exercise testing in a regional paediatric cystic fibrosis centre in the UK
11. 267 Increasing rates of obesity in CF children in the South West of England over the last decade
12. 251 Should %ideal body weight (%IBW) or body mass index percentile (BMIp) be used to assess growth in children with cystic fibrosis?
13. 203 A review of the use of hypertonic saline 7% during inpatient treatment in paediatric cystic fibrosis patients
14. WS20.6 Comparison of microbial composition in the lower airway of young children with and without cystic fibrosis using 16S rRNA gene pyrosequencing
15. EPS3.01 A comparison of routine cough swabs vs a novel sputum sampling technique in a paediatric population.
16. Cassava Mosaic Virus Disease in East and Central Africa: Epidemiology and Management of A Regional Pandemic.
17. Hematoma infection with Mycoplasma hominis following transplant nephrectomy.
18. Substitution-inert metal ions as probes of biological function
19. Complexes of cobalt(III) with flexible tetradentate ligands
20. EPS7.06 Cardiovascular function in people with cystic fibrosis established on elexacaftor/tezacaftor/ivacaftor modulator therapy.
21. 4P CBL-B inhibition overcomes PD-1/LAG-3 mediated resistance in lung cancer.
22. P454 Body composition and peripheral muscle function in people with cystic fibrosis established on elexacaftor/tezacaftor/ivacaftor.
23. P015 Innovating CF diagnosis in resource-limited settings: The efficacy of salivary chloride detection strips.
24. WS11.01 The use of salivary chloride levels as a screening tool to identify children with cystic fibrosis.
25. 170 Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis and at least one F508del allele: 144-week interim results from an open-label extension study.
26. Structural characterization of octahedral metal complexes of [MX 3(py) 3] type with three pyridines as revealed by 2H NMR spectra
27. PCN122 Pilot Survey to Estimate Willingness to Pay (WTP) for Prophylactic Granulocyte Colony-Stimulating Factors (G-CSFs) Among Previously Treated Breast Cancer Patients
28. PCN129 USE OF ELECTRONIC MEDICAL RECORDS (EMR) FOR ONCOLOGY OUTCOMES RESEARCH: ASSESSING THE COMPARABILITY OF EMR INFORMATION TO PATIENT REGISTRY AND HEALTH CLAIMS DATA
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.